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BACKGROUND: Current electrocardiographic algorithms lack sensitivity to diagnose acute myocardial infarction (AMI) in the 
presence of left bundle branch block.
METHODS AND RESULTS: A multicenter retrospective cohort study including consecutive patients with suspected AMI and left 
bundle branch block, referred for primary percutaneous coronary intervention between 2009 and 2018. Pre- 2015 patients 
formed the derivation cohort (n=163, 61 with AMI); patients between 2015 and 2018 formed the validation cohort (n=107, 40 
with AMI). A control group of patients without suspected AMI was also studied (n=214). Different electrocardiographic criteria 
were tested. A total of 484 patients were studied. A new electrocardiographic algorithm (BARCELONA algorithm) was derived 
and validated. The algorithm is positive in the presence of ST deviation ≥1 mm (0.1 mV) concordant with QRS polarity, in any 
lead, or ST deviation ≥1 mm (0.1 mV) discordant with the QRS, in leads with max (R|S) voltage (the voltage of the largest deflec-
tion of the QRS, ie, R or S wave) ≤6 mm (0.6 mV). In both the derivation and the validation cohort, the BARCELONA algorithm 
achieved the highest sensitivity (93%–95%), negative predictive value (96%–97%), efficiency (91%–94%) and area under the 
receiver operating characteristic curve (0.92–0.93), significantly higher than previous electrocardiographic rules (P<0.01); the 
specificity was good in both groups (89%–94%) as well as the control group (90%).
CONCLUSIONS: In patients with left bundle branch block referred for primary percutaneous coronary intervention, the 
BARCELONA algorithm was specific and highly sensitive for the diagnosis of AMI, leading to a diagnostic accuracy compara-
ble to that obtained by ECG in patients without left bundle branch block.
Key Words: acute myocardial infarction ■ electrocardiography ■ left bundle branch block ■ primary percutaneous coronary 
intervention
The electrocardiographic diagnosis of acute myo-cardial infarction (AMI) in patients with left bundle branch block (LBBB) is often challenging. On one 
hand, most of patients referred for primary percutane-
ous coronary intervention (pPCI) because of the pres-
ence of LBBB are not experiencing an AMI.1 On the 
other hand, patients with LBBB and AMI are usually 
at high risk and often experience delays in reperfusion 
therapy1 that may lead to critical consequences.2,3
Unfortunately, even the most recent electrocardio-
graphic algorithms4,5 do not afford a diagnostic cer-
tainty for AMI in patients with LBBB.2,5,6 In the absence 
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of acute ischemia, the LBBB pattern is characterized 
by (1) ST- segment displacement in the opposite direc-
tion to the polarity of the QRS complex (further referred 
as discordant ST deviation) and (2) the existence of a 
certain degree of proportionality between the magni-
tude of the discordant ST deviation and the voltage of 
the corresponding QRS complex.4,5,7 Thus, in addition 
to the clinical symptoms of acute ischemia, the occur-
rence of ST elevation concordant with QRS polarity 
(5 points in Sgarbossa rules, referred to as concordant 
ST elevation) and the presence of excessive discordant 
ST deviation (such as the ST/QRS ratio in the Modified 
Sgarbossa Criteria)5 are specific for AMI. However, 
these criteria have a relatively low sensitivity.2,5,6
To improve the diagnostic sensitivity of ECG in pa-
tients with LBBB and suspected AMI, we have elabo-
rated 2 new approaches. First, since any ST deviation 
concordant with the QRS should be regarded as ab-
normal, we hypothesized that not only concordant ST 
elevation but also concordant ST depression might be 
a sign of AMI; we therefore extended the Sgarbossa 
rule of concordant ST depression in leads V1 to V3 
to any other lead. It was hypothesized that this would 
cover the electrocardiographic projection of acute 
ischemia in different myocardial regions.
Second, we considered as a positive criterion for 
AMI the presence of an appreciable (≥1 mm or 0.1 mV) 
discordant ST deviation in low- voltage QRS complexes 
because, in the absence of ischemia, these complexes 
usually show isoelectric ST- segment potentials (Figure 1). 
This latter criterion had not yet been explored and re-
quired defining the best cutoff value for QRS voltage 
below which any discordant ST deviation ≥1 mm (0.1 mV) 
would be regarded as disproportionate and suggestive of 
AMI. Of note, leads with low- voltage QRS are a frequent 
finding in patients with LBBB and AMI, since AMI is as-
sociated with lower QRS voltages in patients with LBBB.8
The objective of this study was to assess whether 
the electrocardiographic diagnosis of AMI in the pres-
ence of LBBB improved by considering the presence 
of concordant ST depression in any ECG lead and the 
occurrence of discordant and disproportionate ST de-
viation in leads with low- voltage QRS complexes.
METHODS
The data that support the findings of this study are 
available from the corresponding author upon reason-
able request.
Study Design and Patient Selection
This is a retrospective, observational cohort study in-
volving 4 referral hospitals for pPCI in Barcelona, Spain. 
The “Codi IAM” network9 in Catalonia (Spain) provides 
early reperfusion, mainly through pPCI, to all patients 
with suspected ST- segment–elevation myocardial in-
farction (STEMI) presenting during the first 12  hours 
after the onset of symptoms. According to the Codi 
IAM protocol, the presence of new or presumed new 
LBBB in association with ischemic symptoms is con-
sidered an indication for pPCI.
In this study, we included all consecutive patients re-
ferred for pPCI because of new or presumed new LBBB 
with available ECG recorded at the first medical contact.
The cohort of patients referred for pPCI between 
October 2009 and December 2014 formed the deriva-
tion sample, while patients referred from January 2015 
until June 2018 served as the validation sample.
In addition, to evaluate the specificity of the proposed 
new electrocardiographic criteria in patients not sus-
pected of having an AMI, we included a control group of 
consecutive patients with complete LBBB who attended 
the emergency department of Bellvitge University 
Hospital for any reason other than acute coronary syn-
drome or who were referred to this center for electro-
physiological study or cardiac pacemaker implantation.
The clinical data were retrieved from prospective da-
tabases available at each participating hospital. These 
databases register all patients with STEMI treated 
within the Codi IAM protocol since the beginning of this 
CLINICAL PERSPECTIVE
What Is New?
• We have identified and validated a new electro-
cardiographic algorithm, named the BARCELONA 
algorithm, that significantly improves the per-
formance of previous electrocardiographic cri-
teria to diagnose acute myocardial infarction in 
patients with left bundle branch block.
What Are the Clinical Implications?
• To improve the electrocardiographic diagnosis 
of acute myocardial infarction in patients with 
left bundle branch block will help to reduce 
many false activations of the protocols for emer-
gent reperfusion and will help to provide timely 
reperfusion to those patients who are truly ex-
periencing an acute myocardial infarction.
Nonstandard Abbreviations and Acronyms
AMI acute myocardial infarction
pPCI  primary percutaneous coronary 
intervention
ROC receiver operating characteristicD
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network in 2009. The study protocol was approved by 
the Institutional Ethics Committee; the Committee con-
sidered that, given the retrospective nature of the anal-
ysis and the use of anonymized data, written informed 
consent from patients was not needed.
Electrocardiographic Analysis
All ECGs were recorded at 25 mm/s speed, 10 mm/
mV amplitude.
The ECGs were analyzed by 2 independent car-
diologists from the coordinating center (Bellvitge 
Hospital), who were blinded to the clinical and an-
giographic data. In case of discordance, the evalu-
ation of a third cardiologist was required. LBBB was 
defined by the presence of QRS complex duration 
>120 ms; QS or rS pattern in lead V1; R- wave peak 
time >60  ms in leads DI, V5, or V6; and absence 
of Q wave in these leads.4,10 The ST deviation was 
measured at the J point relative to the QRS onset, 
and all voltage measurements >1 mm (0.1 mV) were 
rounded to the nearest 0.5 mm (0.05 mV); ST devia-
tions <1 mm (0.1 mV) were not taken into account. To 
mitigate the potential influence of an unstable record-
ing baseline and interbeat ST and QRS variability on 
our results, we considered an electrocardiographic 
criterion positive when it was present in >50% of the 
beats available in 1 lead.
The new electrocardiographic criteria evaluated 
in this study are (1) the presence of ST depression 
≥1  mm (0.1  mV) concordant with QRS polarity in 
any lead of the ECG (Figure 2 and Figure S1) and (2) 
the occurrence of discordant ST deviation ≥1  mm 
(0.1 mV) in leads with a low- voltage QRS (Figure 3, 
Figure 4, and Figure S1). QRS polarity was consid-
ered as positive or negative whenever the largest 
Figure 1. ECG from a patient without acute myocardial infarction showing isoelectric ST segment or minimal ST deviation 
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deflection of the QRS was ≥1.5mm (0.15mV) higher 
as compared to the opposite deflection. Leads 
where the difference between the voltages of the 
R wave and the Q or S waves were ≤1mm (0.1mV) 
were not taken into account. To evaluate low- 
voltage QRS, we considered the voltage of the larg-
est deflection of the QRS (ie, the R wave in leads 
with a predominantly positive QRS and the Q or S 
wave in leads with a predominantly negative QRS), 
measured with respect to QRS onset; we defined 
this variable as max (R|S) voltage.5To accomplish 
this second criterion, we needed to find the best 
cutoff value for max (R|S) voltage, below which any 
discordant ST deviation ≥1 mm (0.1 mV) would be 
regarded as abnormal and then support the diag-
nosis of AMI. This cutoff value was derived from the 
receiver operating characteristic (ROC) curves for 
max (R|S) voltages ranging from 4 mm (0.4 mV) to 
8 mm (0.8 mV). The best cutoff was defined by the 
highest area under the ROC curve and the highest 
efficiency.
We hypothesized that the highest sensitivity would 
be achieved by an algorithm that took into account 
all potential aspects of repolarization abnormalities in 
LBBB, that is, concordant ST elevation, concordant ST 
depression, and disproportionate discordant ST devia-
tion in leads with a low- voltage QRS.
The Sgarbossa and Modified Sgarbossa Criteria 
were applied according to previously published defini-
tions4,5 (Table S1).
Clinical Variables
In each patient, we recorded clinical and anthropo-
metric variables, laboratory tests, and electrocardio-
graphic and angiographic data. AMI was diagnosed 
in the presence of either an acute coronary artery 
occlusion (grade 0 of the thrombolysis in myocar-
dial infarction flow grading) or an acute coronary 
lesion with thrombolysis in myocardial infarction 
flow ≥1 associated with a troponin rise and fall 
above the 99th percentile upper reference limit. 
Coronary stenosis was considered acute when 
Figure 2. ECG from a patient with acute myocardial infarction and culprit lesion in the right coronary artery, showing ST- 
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signs of  thrombosis or ulceration were identified by 
angiography.
The diagnosis of STEMI is based on electrocar-
diographic criteria that do not apply to patients with 
LBBB. To test the diagnostic performance of the 
Modified Sgarbossa rules, Smith and coworkers5 
elaborated a definition of STEMI equivalent based on 
angiographic findings and the amount of the release 
of biomarkers of cardiac injury. To get closer to the 
concept of STEMI equivalent used in the Modified 
Sgarbossa Criteria, we elaborated a similar defini-
tion of STEMI equivalent (see Data S1) and tested 
the diagnostic performance of the new electrocar-
diographic criteria by including patients with STEMI 
equivalent in a separate analysis (see Data S1 and 
Table S2).
Statistical Analysis
Continuous variables are presented as mean and SD 
or median and interquartile range. Categorical vari-
ables are expressed as numbers and percentages. 
Comparisons between groups were performed using 
the t test or the Mann–Whitney U test for continuous 
variables and the chi- squared test or Fisher’s exact test 
for categorical variables. The 95% CIs were obtained 
using Wald’s or Wilson’s method when appropriate. 
Sensitivity and specificity of each electrocardiographic 
algorithm were compared using McNemar’s test. 
Global performance of each algorithm was assessed 
by calculating the efficiency and the area under the 
ROC curve. Efficiency is a parameter that expresses 
the percentage of correct classifications by a diag-
nostic test, and it is calculated as follows: 100×(true 
negatives+true positives)/all cases. Areas under the 
ROC curve were compared using the algorithm pro-
posed by De Long et al.11 The added value of the new 
criteria was calculated by the Integrated Discrimination 
Improvement index and the Net Reclassification 
Improvement index.12 The agreement between the 2 
cardiologists who interpreted the ECGs was evalu-
ated with the Cohen’s kappa coefficient. Differences 
were considered statistically significant at the 2- sided 
P<0.05 level. The statistical analysis was performed 
with STATA Release 12 software (StataCorp LP, 
College Station, TX).
RESULTS
The study included 484 patients divided into 3 
groups: (1) a derivation cohort formed by 163 pa-
tients who were referred for pPCI between October 
2009 and December 2014, (2) a validation cohort in-
cluding 107 patients referred for pPCI from January 
2015 until June 2018, and (3) a control group of 214 
Figure  3. ECG from a patient with acute myocardial infarction and culprit lesion in the left circumflex artery, showing 
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patients with LBBB and no suspected acute coro-
nary syndrome. The 2 cardiologists who analyzed 
the ECGs agreed completely on the evaluation of 
the Sgarbossa criteria. There were 4 cases (1.5%) of 
disagreement concerning the Modified Sgarbossa 
Criteria and 2 cases (0.7%) of disagreement with 
the BARCELONA algorithm, all in patients referred 
for pPCI. The Cohen’s kappa coefficient was 0.96 
for the Modified Sgarbossa criteria and 0.98 for the 
BARCELONA algorithm.
Baseline Characteristics of Patients 
Referred for pPCI
There were no significant differences in terms of car-
diovascular risk factors, cardiac history, and in- hospital 
Figure 4. ECG from a patient with acute myocardial infarction and culprit artery in the left main.
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death between the derivation and the validation samples 
(Table 1).
AMI was diagnosed in 61 patients (37%) in the 
derivation cohort and in 40 patients (37%) in the 
validation sample. As compared with those without 
a diagnosis of AMI, patients with AMI were more 
frequently men, had higher prevalence of diabetes 
mellitus, dyslipidemia, and prior myocardial infarc-
tion, as well as lower left ventricular ejection fraction 
(Table  1). Clinical and angiographic details of pa-
tients with AMI are presented in Table 2. There were 
no significant differences in AMI characteristics and 
severity between the derivation and validation co-
hort (Table  2). Overall, the clinical presentation of 
the AMI was often severe: 40% of patients were in 
Killip class III or IV, the median left ventricular ejec-
tion fraction was 40%, and the in- hospital mortality 
was 15%.
Baseline Characteristics of Patients With 
No Suspected AMI
The control group included 23 cases referred for 
electrophysiological study after syncope, 96 pa-
tients referred for pacemaker implantation and 95 
patients attended at the emergency department. The 
complete list of final diagnoses at the emergency 
department is reported in Table S3. The baseline 
characteristics of the control group are reported in 
Table 1. Almost half of patients (46%) had structural 
heart disease, and the median left ventricular ejec-
tion fraction was 56%.
ECG Analysis in the Derivation Cohort
The Sgarbossa and Modified Sgarbossa rules showed 
a high specificity (up to 98% for Sgarbossa score ≥3) 
but a low sensitivity (range, 26%–62%) for the diagno-
sis of AMI in the presence of LBBB (Table 3).
The Sgarbossa rule of ST depression limited to ECG 
leads V1 to V3 had a sensitivity of 13%. By extending the 
analysis to concordant ST depression ≥1 mm (0.1 mV) in 
any ECG lead the sensitivity increased to 51% (P<0.01) 
still maintaining a 97% specificity (Table 4).
The best cutoff value of max (R|S) voltage indi-
cating low- voltage QRS with disproportionate dis-
cordant ST deviation was 6 mm (0.6 mV). This max 
(R|S) voltage gave the highest efficiency (86%) and 
the highest area under the ROC curve (0.84), signifi-
cantly higher than other values (Figure 5). Thus, the 
new criterion was positive in the presence of discor-
dant ST deviation ≥1 mm (0.1 mV) in any ECG lead 
with a max (R|S) voltage ≤6 mm (0.6 mV). Of note, 
in line with previous studies,7 patients with AMI had 
lower QRS voltage (mean max [R|S] voltage 9.6 mm 
or 0.96  mV versus 10.8  mm or 0.108  mV; P=0.01) 
Table 1. Clinical Characteristics of the Study Population
Patients With Suspected AMI Referred for pPCI (N=270) Patients With No 
Suspected AMI 





Cohort (N 107) P Value AMI (N 101)
No AMI 
(N 169) P Value
Age, y, median (IQR) 72 (62–78) 73 (65–82) 0.23 73 (64–80) 71 (63–79) 0.53 79 (72–85)
Sex, male 97 (60%) 60 (56%) 0.58 75 (74%) 82 (49%) <0.01 97 (46%)
Risk factors/comorbidities
Hypertension 125 (77%) 78 (73%) 0.48 81 (80%) 122 (72%) 0.14 179 (84%)
Dyslipidemia 97 (60%) 66 (62%) 0.72 76 (75%) 87 (51%) <0.01 128 (60%)
Diabetes mellitus 58 (36%) 45 (42%) 0.28 46 (46%) 57 (34%) 0.05 87 (41%)




73 (45%) 46 (43%) 0.77 45 (45%) 75 (44%) 0.98 99 (46%)
Prior MI 24 (15%) 21 (20%) 0.29 24 (24%) 21 (13%) 0.02 25 (12%)
History of AF 28 (17%) 15 (14%) 0.49 11 (11%) 32 (19%) 0.08 65 (30%)
LVEF (%), 
median (IQR)
45 (35–60) 47 (35–60) 0.66 40 (33–50) 50 (35–60) <0.01 56 (46–60)*
Admission data
Hospital stay (d), 
median (IQR)
4 (1–9) 5 (1–10) 0.03 6 (4–11) 2 (1–8) <0.01 NA
In hospital death 11 (7%) 13 (12%) 0.13 15 (15%) 9 (5%) <0.01 NA
Chi squared or the Fisher exact test when appropriate were used to calculate differences between proportions; the Mann–Whitney U test was used to 
calculate differences between medians. AF indicates atrial fibrillation; AMI, acute myocardial infarction; IQR, interquartile range; LVEF, left ventricular ejection 
fraction; MI, myocardial infarction; NA, not available; and pPCI, primary percutaneous coronary intervention.
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and the median number of leads with max (R|S) volt-
age ≤6 mm (0.6 mV) was higher in patients with AMI 
(5 versus 3; P=0.02).
We tested several ECG algorithms incorporating 
the new criteria (Table 4). The best performance and 
the highest sensitivity were obtained by the algorithm 
Table 2. Angiographic, Clinical, and Laboratory Data of Patients With Left Bundle Branch Block and Acute Myocardial 
Infarction
All Patients, N=101 (%) Derivation Sample, N=61 (%) Validation Sample, N=40 (%) P Value
Acute occlusion (TIMI 0) 49 (49) 29 (48) 20 (50) 0.81
Acute lesion with TIMI 1–2 24 (24) 15 (25) 9 (23) 0.81
Acute lesion with TIMI 3 28 (28) 17 (28) 11 (28) 0.97
Multivessel disease* 57 (56) 37 (61) 20 (50) 0.29
Culprit artery 0.39
Left main 9 (9) 4 (7) 5 (14)
LAD territory 48 (48) 29 (48) 19 (48)
LCx territory 21 (21) 15 (25) 6 (16)
RCA territory 18 (18) 10 (16) 8 (22)
Intermediate artery 3 (3) 3 (5) 0 (0)
Killip class at admission 0.78
I 53 (52) 32 (52) 21 (53)
II 8 (8) 4 (7) 4 (11)
III 22 (23) 15 (25) 7 (18)
IV 18 (19%) 10 (17) 8 (21)
TnT or TnI ratio, median 
(IQR)
171 (53–680) 194 (55–857) 149 (47–677) 0.52
CK- MB ratio, median (IQR) 23 (5–64) 23 (5–64) 23 (7–78) 0.94
The Pearson chi- squared or the Fisher exact test when appropriate was used to calculate differences between proportions; the Mann–Whitney U test was 
used to calculate differences between medians. CK- MB indicates creatine kinase isoenzyme MB; LAD, left anterior descendending artery; LCx, left circumflex 
artery; RCA, right coronary artery; STEMI, ST- segment–elevation myocardial infarction; TIMI, thrombolysis in myocardial infarction flow grade; TnI, troponin I; 
and TnT, troponin T.
*Significant coronary stenosis in at least 2 coronary arteries.






(95% CI) PPV % (95% CI) NPV % (95% CI)
Efficiency % 




34 (24–47) 98 (93–100) 91 (73–98) 71 (64–78) 74 (67–80) 0.66 (0.60–0.72)
Sgarbossa score 
≥2
48 (36–60) 84 (76–90) 64 (50–77) 73 (64–80) 71 (63–77) 0.66 (0.59–0.73)
Mod. Sgarbossa III 62 (50–73) 91 (84–95) 81 (68–89) 80 (72–86) 80 (74–86) 0.77 (0.70–0.83)
Mod. Sgarbossa IV 51 (39–63) 96 (90–99) 89 (74–96) 77 (69–83) 79 (72–85) 0.73 (0.67–0.80)
Mod. Sgarbossa V 26 (17–38) 97 (92–99) 84 (62–95) 69 (61–76) 71 (63–77) 0.62 (0.56–0.67)




33 (20–48) 99 (92–100) 93 (69–99) 71 (61–80) 74 (65–81) 0.66 (0.58–0.74)
Sgarbossa score 
≥2
40 (26–55) 85 (75–92) 62 (43–78) 70 (60–79) 68 (59–76) 0.63 (0.54–0.72)
Mod. Sgarbossa III 68 (52–80) 94 (86–98) 87 (71–95) 83 (73–90) 84 (76–90) 0.80 (0.72–0.88)
Mod. Sgarbossa IV 50 (35–65) 96 (88–99) 87 (68–96) 76 (66–84) 79 (70–85) 0.73 (0.65–0.82)
Mod. Sgarbossa V 28 (17–44) 97 (90–99) 85 (58–96) 70 (60–78) 72 (63–79) 0.63 (0.55–0.70)
BARCELONA 93 (80–97) 94 (86–98) 90 (78–96) 96 (88–98) 94 (87–97) 0.93 (0.88–0.98)
AMI indicates acute myocardial infarction; AUC, area under the curve; Mod. Sgarbossa III, IV and V Smith’s Modified Sgarbossa rule III, IV and V; NPV, 
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that provided the most comprehensive approach to re-
polarization abnormalities in LBBB and included con-
cordant ST deviation >1 mm (0.1 mV) in any lead and 
discordant ST deviation ≥1 mm (0.1 mV) in leads with 
max (R|S) voltage ≤6 mm (0.6 mV). This algorithm was 
named BARCELONA algorithm and is described in de-
tail in Table 5.
The BARCELONA algorithm attained the highest 
sensitivity (95%), significantly higher (P<0.01) than 
Sgarbossa and Modified Sgarbossa rules, as well as 
the highest negative predictive value (97%), while main-
taining 89% specificity (Table 3 and Table 6). The global 
performance of the BARCELONA algorithm was sig-
nificantly better than previous algorithms: It achieved 
the highest efficiency (91%) and the highest area under 
the ROC curve (0.92), which was significantly higher 
(P<0.01) than the ones obtained by the Sgarbossa and 
Modified Sgarbossa rules (Figure 6). The BARCELONA 
algorithm also afforded a significant improvement 
in the ability to predict the occurrence of an AMI, as 
shown by Integrated Discrimination Improvement and 
Net Reclassification Improvement indexes (both in-
dexes showed P<0.01 comparing BARCELONA algo-
rithm with Sgarbossa and Modified Sgarbossa rules).





(95% CI) PPV% (95% CI) NPV% (95% CI)
Efficiency% 
(95% CI) AUC ROC (95% CI)
Derivation cohort (N=163)
Concordant ST depression 51 (39–63) 97 (92–99) 91 (77–97) 77 (69–83) 80 (73–85) 0.74 (0.67–0.80)
Disc- ST- max (R|S) ≤6 mm 
(0.6 mV)




85 (74–92) 90 (83–95) 84 (73–91) 91 (84–95) 88 (83–92) 0.88 (0.82–0.93)





69 (56–79) 96 (90–99) 91 (80–97) 84 (76–89) 86 (80–90) 0.82 (0.76–0.89)
Concordant ST elevation
Any of
Disc- ST- max (R|S) 
≤6 mm (0.6 mV)
92 (82–96) 90 (83–95) 85 (74–92) 95 (85–94) 91 (85–94) 0.91 (0.86–0.96)
Concordant ST elevation
BARCELONA algorithm 95 (86–98) 89 (82–94) 84 (74–91) 97 (91–99) 91 (86–95) 0.92 (0.88–0.96)
Validation cohort (N=101)
Concordant ST Depression 40 (26–55) 99 (92–100) 94 (72–99) 74 (64–82) 77 (68–84) 0.69 (0.61–0.77)
Disc- ST- max (R|S) ≤6 mm 
(0.6 mV)




78 (63–88) 94 (86–98) 89 (74–96) 88 (78–93) 88 (80–93) 0.85 (0.78–0.93)





55 (40–69) 99 (92–99) 96 (79–99) 79 (69–86) 82 (74–88) 0.78 (0.70–0.86)
Concordant ST elevation
Any of
Disc- ST- max (R|S) 
≤6 mm (0.6 mV)
83 (68–91) 94 (86–98) 89 (75–96) 90 (81–95) 90 (83–94) 0.88 (0.81–0.95)
Concordant ST elevation
BARCELONA algorithm 93 (80–97) 94 (86–98) 90 (78–96) 96 (88–98) 94 (87–97) 0.93 (0.88–0.98)
Concordant ST depression, ST depression ≥1 mm (0.1 mV) concordant with QRS polarity, in any lead; Disc- ST- max (R|S)≤6 mm (0.6 mV), ST deviation 
≥1 mm (0.1 mV) discordant with the QRS in any lead with max (R|S) voltage ≤6 mm (0.6 mV); Concordant ST elevation, ST. Elevation ≥1 mm (0.1 mV) concordant 
with QRS polarity, in any lead ST, corresponding to Sgarbossa score of 5. AUC indicates area under the curve; NPV, negative predictive value; PPV, positive 
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Figure 5. Diagnostic performance and receiver operating characteristic (ROC) curves for 
the diagnosis of acute myocardial infarction using discordant ST deviation ≥1 mm (0.1 mV) in 
leads with a low- voltage QRS.
We show the results of the best cutoffs for the max (R|S) voltage used to define low- voltage QRS, in 
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ECG Analysis in the Validation Cohort
Sgarbossa and Modified Sgarbossa rules showed 
a high specificity (up to 99%) but a limited sensitivity 
(28%–68%) (Table 3), confirming the results of the deri-
vation cohort.
A max (R|S) voltage value ≤6  mm (0.6  mV) also 
achieved the highest efficiency (81%) and highest area 
under the ROC curve (0.77) among the cutoff values 
tested to define a low- voltage QRS where dispro-
portionate discordant ST deviation ≥1 mm (0.1 mV) is 
suggestive of AMI (Figure  5). Likewise, the validation 
cohort confirmed that, extending the analysis of con-
cordant ST depression ≥1  mm (0.1  mV) to any ECG 
lead (instead of limiting it to leads V1–V3) resulted in a 
significant increase of diagnostic sensitivity (from 10% 
to 40%; P<0.01).
The BARCELONA algorithm attained a 93% sen-
sitivity, which was significantly higher than that of the 
Sgarbossa and Modified Sgarbossa rules (P<0.01 
and P<0.01, respectively). It also reached the high-
est negative predictive value (96%) and maintained a 
94% specificity, which was not inferior to Sgarbossa 
and Modified Sgarbossa rules (Tables 3 and 7). The 
global performance of the BARCELONA algorithm 
was significantly better than previous algorithms: It 
achieved the highest efficiency (94%) and the highest 
area under the ROC curve (0.93), which was signifi-
cantly higher (P<0.01) than the ones obtained by the 
Sgarbossa and Modified Sgarbossa rules (Figure 6).
Diagnostic Yielding of the ECG in the 
Entire Cohort of Patients Referred for pPCI
The application of a Sgarbossa score ≥3 and the 
Modified Sgarbossa rules in our entire cohort of 270 
patients with LBBB referred for pPCI (101 diagnosed 
with AMI) would have missed 67 and 36 patients with 
AMI, respectively. By contrast, the BARCELONA algo-
rithm would have missed only 6 patients.
The influence of coronary reperfusion on the elec-
trocardiographic algorithms could be evaluated in 75 
patients with AMI in whom an ECG recorded within the 
first 48 hours after pPCI was available. After pPCI, the 
BARCELONA algorithm became negative in 93% of pa-
tients with AMI who were positive before reperfusion.
Control Population
The BARCELONA algorithm was positive in 21 of 
214 patients (10%), thus achieving a 90% specificity. 
Among these 21 patients, 2 had ST elevation ≥1 mm 
(0.1 mV) concordant with QRS polarity, 1 had concord-
ant ST depression ≥1 mm (0.1 mV), 17 had discordant 
ST deviation ≥1 mm (0.1 mV) in leads with max (R|S) 
voltage ≤6 mm (0.6 mV), and 1 had both ST- segment 
elevation ≥1 mm (0.1 mV) concordant with QRS polar-
ity and discordant ST deviation ≥1 mm (0.1 mV) in leads 
with max (R|S) voltage ≤6 mm (0.6 mV). Thus, in this 
control group, the majority (81%) of false- positive cases 
of the BARCELONA algorithm were attributable to the 
presence of discordant ST deviation ≥1 mm (0.1 mV) in 
leads with max (R|S) voltage ≤6 mm (0.6 mV).
DISCUSSION
Main Findings and Strengths of the Study
This study shows that the diagnostic accuracy for AMI 
in the presence of LBBB was significantly improved by 
considering 2 new electrocardiographic criteria: (1) the 
finding of ST depression ≥1 mm (0.1 mV) concordant 
with QRS polarity in any ECG lead and (2) the existence 
of ST deviation ≥1 mm (0.1 mV) discordant with QRS 
polarity in any ECG lead with low- voltage QRS, with 
the optimal cutoff for low- voltage QRS established as 
max (R|S) voltage ≤6 mm (0.6 mV).
To our knowledge, this is the largest cohort of pa-
tients with LBBB referred for pPCI used to evaluate elec-
trocardiographic algorithms to diagnose AMI. Patients 
Table 5. Definition of the BARCELONA Algorithm to 
Diagnose AMI in the Presence of LBBB
The BARCELONA algorithm is positive if any of the following criteria are 
present:
(1) ST deviation ≥1 mm (0.1 mV) concordant with QRS polarity in any 
ECG lead, thus including either:
• ST depression ≥1 mm (0.1 mV) concordant with QRS polarity, in any 
ECG lead.
• ST elevation ≥1 mm (0.1 mV) concordant with QRS polarity, in any 
ECG lead (Sgarbossa score 5).
(2) ST deviation ≥1 mm (0.1 mV) discordant with QRS polarity, in any 
lead with max (R|S) voltage ≤6 mm (0.6 mV).
AMI indicates acute myocardial infarction; and LBBB, left bundle branch 
block.
Table 6. Comparison of the Main Algorithms Regarding 
Sensitivity and Specificity for AMI in the Derivation Sample
Algorithm
Sensitivity 






95 (86–98) 89 (82–94)
Sgarbossa score 
≥3
34 (24–47) <0.01 98 (93–100) <0.01
Sgarbossa score 
≥2
48 (36–60) <0.01 84 (76–90) 0.33
Modified 
Sgarbossa rule III




51 (39–63) <0.01 96 (90–99) 0.07
Modified 
Sgarbossa rule V
26 (17–38) <0.01 97 (92–99) 0.04
The reference value to calculate the P value is the BARCELONA algorithm. 





 http://ahajournals.org by on February 19, 2021
J Am Heart Assoc. 2020;9:e015573. DOI: 10.1161/JAHA.119.015573 12
Di Marco et al Improved Electrocardiographic Diagnosis of AMI With LBBB
with LBBB referred for pPCI are the target population 
that could benefit the most from an improved electro-
cardiographic diagnosis of AMI. Because of the lack 
of a reliable electrocardiographic diagnosis of AMI, 
these patients are often overtreated. Indeed, in our 
study, 63% of patients were unnecessarily exposed to 
Figure 6. Receiver operating characteristic (ROC) curves of ECG algorithms for the diagnosis 
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an emergent reperfusion protocol, which has inherent 
risks and an elevated economic cost. Moreover, the 
availability of angiographic data in patients referred 
for pPCI allowed us to establish a reliable diagnosis of 
AMI, overcoming the limitation of some previous stud-
ies where the diagnosis of AMI was confirmed only by 
cardiac biomarkers.4
The type of study (cohort study) also permitted cal-
culation of positive predictive value and negative pre-
dictive value, which could not be performed in previous 
case- control studies.4,5 This was an “all comers” study, 
as we did not select or exclude patients with certain 
clinical variables. Therefore, the results may be widely 
applicable to patients with LBBB and suspected AMI. 
Finally, the specificity of the proposed criteria was also 
tested in a control population without suspected acute 
coronary syndrome.
Electrocardiographic Diagnosis of AMI in 
the Presence of LBBB
Our results show that concordant ST deviations are 
extremely specific for AMI. This was already known for 
concordant ST elevation ≥1 mm (0.1 mV) (Sgarbossa 
score 5) but had not been demonstrated for concord-
ant ST depression ≥1  mm (0.1  mV) in any lead. As 
described in Table 1 in their manuscript,4 Sgarbossa 
and colleagues analyzed the ST- segment concord-
ance or discordance with QRS polarity only for ST el-
evation. By contrast, they evaluated the presence of 
ST depression in any lead without correlating it with 
QRS polarity. They found that ST depression in leads 
V1 to V3 was suggestive of AMI, since leads V1 to 
V3 generally display a negative QRS in patients with 
LBBB. However, such analysis without correlating ST 
depression with QRS polarity could miss the clinical 
relevance of concordant ST deviations occurring in 
those ECG leads that can have either a negative or 
a positive QRS in different patients with LBBB. In our 
series, when concordant ST depression was present, 
it occurred in leads other than V1 to V3 in the vast 
majority of patients with AMI, and these patients would 
have been missed by the Sgarbossa rules. Thus, we 
confirmed the hypothesis that by evaluating concord-
ant ST depression in any lead, we could improve the 
sensitivity of the ECG to detect ischemia in different 
myocardial regions.
In patients with LBBB, it has been demonstrated 
that acute ischemia is associated with an increase 
in the magnitude of ST deviations discordant with 
QRS polarity7,13 so that they become disproportion-
ately greater than would be expected by the voltage 
of the QRS in the corresponding lead. By using a new 
approach, we could identify a max (R|S) voltage of 
6 mm (0.6 mV) as the best cutoff for disproportionate 
discordant ST deviations ≥1 mm (0.1 mV) suggestive 
of AMI.
The BARCELONA algorithm incorporated a com-
prehensive approach to repolarization abnormalities 
in patients with LBBB by including concordant ST de-
viations ≥1  mm (0.1  mV) in any lead and discordant 
ST deviations in leads with max (R|S) voltage ≤6 mm 
(0.6 mV). This algorithm significantly improved the sen-
sitivity of the ECG to diagnose AMI in patients with 
LBBB, achieving similar results to those obtained by 
the ECG in patients without LBBB.14 It also had a high 
negative predictive value: When the algorithm is nega-
tive, the probability of AMI seems very low.
The BARCELONA algorithm also had good spec-
ificity and positive predictive value: only 9% of pa-
tients without AMI would have still been transferred 
for emergent reperfusion by using the new algorithm. 
This percentage is in agreement with the prevalence 
of false- positive activation of the pPCI protocol in the 
general population, including patients without LBBB.15 
Moreover, the BARCELONA algorithm confirmed 
a 90% specificity in a large cohort of patients with 
LBBB without suspected acute coronary syndrome.
Of note, among patients with LBBB and AMI in-
cluded in the present study, there was a wide range of 
culprit arteries, including all major coronary branches 
as well as the left main. Thus, the good performance 
of the new algorithm could apply to any AMI location. 
Finally, this new algorithm is simpler as compared with 
the Modified Sgarbossa Criteria and could be widely 
applied without determining a relevant delay in diagno-
sis and reperfusion.
LBBB and Suspected AMI: To Treat or to 
Wait?
The presence of LBBB in patients with ischemic symp-
toms has traditionally been considered an ECG equiv-
alent to ST- segment elevation and the 2017 European 
Society of Cardiology guidelines16 still recommend 
emergent reperfusion in such cases.
Table 7. Comparison of the Main Algorithms Regarding 
Sensitivity and Specificity for AMI in the Validation Sample
Algorithm
Sensitivity 
% (95% CI) P Value
Specificity 
% (95% CI) P Value
BARCELONA 93 (80–97) 94 (86–98)
Sgarbossa 
score ≥3
33 (20–48) <0.01 99 (92–100) 0.08
Sgarbossa 
score ≥2
40 (26–55) <0.01 85 (75–92) 0.08
Smith III 68 (52–80) <0.01 94 (86–98) >0.99
Smith IV 50 (35–65) <0.01 96 (88–99) 0.32
Smith V 28 (17–44) <0.01 97 (90–99) 0.16
The reference value to calculate the P value is the BARCELONA algorithm. 
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However, increasing evidence suggests that LBBB 
is a major cause of false activation of the pPCI pro-
tocol.1 In view of these findings, the 2013 American 
guidelines stated that LBBB should not be considered 
diagnostic of AMI in isolation.17
Until a reliable diagnosis of AMI with LBBB is avail-
able, both strategies have major drawbacks. On the 
one hand, if LBBB is considered an equivalent to ST- 
segment elevation, a majority of patients who have not 
experienced an AMI are unnecessarily exposed to the 
aggressive and costly protocol of emergent reperfu-
sion. This was also confirmed in our cohort where, 
among patients with LBBB referred for pPCI, only 37% 
actually had an AMI (a result in line with previous report 
from other groups).1 On the other hand, if the pPCI pro-
tocol is not directly activated in patients with LBBB and 
ischemic symptoms, the high- risk subgroup of patients 
with LBBB and AMI may not receive timely reperfu-
sion treatment with potential consequences over their 
prognosis.
These considerations highlight the urgent need for 
new ECG criteria to diagnose AMI in the presence of 
LBBB and underline the clinical and also economic 
importance of the present findings to improve the effi-
ciency of pPCI networks.
Recently, clinical algorithms based on the hemo-
dynamic status, on cardiac biomarkers and echo-
cardiographic findings have also been proposed to 
improve the management of patients with LBBB and 
suspected AMI.18,19 However, these algorithms may 
be limited by the high prevalence of initially elevated 
cardiac biomarkers among patients with LBBB with-
out AMI2 and by the limited echocardiographic avail-
ability in small hospitals and emergency services. The 
possibility to achieve a reliable electrocardiographic 
diagnosis of AMI in patients with LBBB would repre-
sent a major step forward. If our results are confirmed 
by other groups, the BARCELONA algorithm could be 
integrated into a wider clinical algorithm, to optimize 
the diagnosis and treatment of patients with LBBB and 
suspected AMI.
LIMITATIONS
The main limitation of the present study is its observa-
tional nature. The relatively wide time frame for post- 
pPCI ECG recordings (immediate to 48  hours) does 
not allow a description of the time course of ECG 
changes after revascularization. Adjustments for multi-
plicity were not performed.
CONCLUSIONS
In 2 cohorts of patients with LBBB referred for pPCI, 
we identified and validated the new ECG algorithm 
BARCELONA based on the presence of concordant 
ST deviation ≥1 mm (0.1 mV) in any ECG lead and/or 
discordant ST deviation ≥1 mm (0.1 mV) in leads with 
max (R|S) voltage ≤6 mm (0.6 mV). This algorithm sig-
nificantly improved the diagnosis of AMI as compared 
with previous ECG rules, achieving a diagnostic perfor-
mance for AMI similar to that of ECG in patients with-
out LBBB. The high specificity of the algorithm was 
confirmed in a large and heterogeneous control group 
of patients without suspected AMI.
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Definition of a STEMI equivalent 
Patients with acute coronary occlusion were considered to have a STEMI equivalent. 
However, between one quarter and one third of STEMI patients have no complete acute 
occlusion of the culprit artery at the time of pPCI.20,21 Therefore the definition of a STEMI 
equivalent needs to be extended also to patients with acute non-occlusive coronary lesions. In 
cases of patent culprit artery, cardiac biomarkers may be a useful discriminator since STEMI is 
associated with higher biomarker release than non-STEMI (NSTEMI).22 Several studies 
analyzed biomarkers ratio (the peak level divided by the upper normal limit): 25% of STEMI 
patients were found to have a cardiac troponin I (cTnI) ratio lower than 4522 and 11% fitted in 
a category of low cardiac troponin (cTn) defined by a lower limit of cTn ratio of 10.23 Creatine 
kinase isoenzyme MB (CK-MB) ratio is usually lower than cTnI22,24,25 ratio and the upper limit 
of the first quartile for CK-MB ratio in STEMI was found to be 8 in a previous study that 
included the largest population investigated so far.22 
In the present study patients with acute non-occlusive coronary lesions were considered 
to have a STEMI if their cardiac troponin I (cTnI) or cardiac troponin T (cTnT) ratios were ≥10 
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In the derivation cohort, out of 61 patients with AMI, 58 (95%) had a STEMI 
equivalent; similar results were obtained in the validation cohort, where, among the 40 
patients with AMI, 38 (95%) had a STEMI equivalent. Both in the derivation and 
validation cohort, the BARCELONA algorithm showed the highest sensitivity, highest 
NPV and highest efficiency for the diagnosis of a STEMI equivalent (Table S3). 
Moreover, both in the derivation and in the validation cohort the BARCELONA 
algorithm had the highest area under the ROC curve, significantly higher (p<0.01) than 
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Table S1. Definition of previously described algorithms. 
     Algorithm Criteria 
Sgarbossa score ≥3 - ST elevation ≥1mm (0.1mV) in any lead concordant with the QRS 
                          and/or 
- ST depression ≥1mm (0.1mV) in leads V1-V3 
Sgarbossa score ≥2 - Sgarbossa score ≥3  
                          and/or 
- ST elevation ≥5mm (0.5mV) in any lead, discordant with the QRS 
Modified Sgarbossa rule III  
 
- Sgarbossa score ≥3 
                          and/or 
- ST elevation/S ≤-0.25 in any lead with ST elevation ≥1mm (0.1mV) 
Modified Sgarbossa rule IV 
 
- Sgarbossa score ≥3  
                          and/or 
- ST deviation/S or R ≤-0.3 in any lead with ST deviation ≥1mm (0.1mV) 
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Table S2. Diagnostic performance of different ECG algorithms for the diagnosis of 
STEMI equivalent.  
Algorithm Sensitivity  
% (95% CI) 
Specificity 
% (95% CI) 
PPV 
% (95% CI) 
NPV 
% (95% CI) 
Efficiency 
% (95% CI) 
AUC ROC 
(95% CI) 
Derivation cohort (N 163)  
Sgarbossa score ≥3 36 (25-49) 98 (93-100) 91 (73-98) 74 (66-80) 76 (69-82) 0.67 (0.61-0.74) 
Sgarbossa score ≥2 50 (38-63) 85 (77-90) 64 (50-77) 75 (67-82) 72 (65-79) 0.67 (0.60-0.75) 
Mod. Sgarbossa III 66 (53-76) 91 (85-95) 81 (68-90) 83 (75-89) 82 (76-87) 0.78 (0.71-0.85) 
Mod. Sgarbossa IV 53 (41-66) 96 (91-99) 89 (74-96) 79 (71-85) 81 (74-86) 0.75 (0.68-0.82) 
Mod. Sgarbossa V 28 (18-40) 97 (92-99) 84 (62-95) 71 (63-78) 72 (65-78) 0.62 (0.56-0.68) 
BARCELONA 95 (86-98) 87 (79-92) 80 (69-88) 97 (91-99) 90 (84-93) 0.91 (0.86-0.95) 
Validation cohort (N 107)  
Sgarbossa score ≥3 34 (21-50) 99 (92-100) 93 (69-99) 73 (63-81) 76 (67-83) 0.67 (0.59-0.75) 
Sgarbossa score ≥2 42 (28-58) 86 (75-92) 62 (43-78) 73 (62-81) 70 (61-78) 0.64 (0.55-0.73) 
Mod. Sgarbossa III 68 (53-81) 93 (84-97) 84 (67-93) 84 (74-91) 84 (76-90) 0.80 (0.72-0.88) 
Mod. Sgarbossa IV 50 (35-65) 94 (86-98) 83 (63-93) 77 (67-85) 79 (70-85) 0.72 (0.64-0.81) 
Mod. Sgarbossa V 27 (15-43) 96 (88-99) 77 (50-92) 71 (61-79) 72 (63-79) 0.61 (0.54-0.69) 
BARCELONA 95 (83-99) 93 (84-97) 88 (75-95) 97 (90-99) 94 (87-97) 0.95 (0.91-0.99) 
CI, confidence interval; NPV, negative predictive value; PPV, positive predictive value; STEMI, ST elevation  
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Table S3. Within the control group of patients with LBB without suspected AMI, 95 
patients were included after a visit at the emergency department due to symtpoms other 
than chest pain and with a final diagnosis different from acute coronary syndrome.  
Diagnosis N (%) 
Decompensated heart failure 16 (17%) 
Syncope/Lipothymia 10 (11%) 
Atrial fibrillation/flutter 9 (9%) 
Decompensated COPD 9 (9%) 
Stroke/TIA 5 (5%) 
Trauma 3 (3%) 
Anemia 3 (3%) 
Pneumonia 3 (3%) 
Seizures 3 (3%) 
Subarachnoid hemorrage 3 (3%) 
Gastritis 3 (3%) 
Rectal bleeding 2 (2%) 
Lower limb ischemia 2 (2%) 
Hepatic encephalopathy 2 (2%) 
Gastroenteritis 2 (2%) 
Perianal abscess 2 (2%) 
Acute kidney failure 2 (2%) 
Sepsis 2 (2%) 
Complications of neoplasm 2 (2%) 
Urinary tract infection 2 (2%) 
Hemoptisis 1 (1%) 
Dehydration 1 (1%) 
Acute confusion 1 (1%) 
Peripheral vertigo 1 (1%) 
Acute pancreatitis 1 (1%) 
Back pain 1 (1%) 
Bipolar disorder 1 (1%) 
High INR (>6) 1 (1%) 
Acute colangitis 1 (1%) 
Deep vein thrombosis 1 (1%) 
The final diagnosis at the emergency department of these patients is reported in the table. 
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Figure S1. ECG from a patient with acute myocardial infarction and culprit lesion in the 
left anterior descending artery. Concordant ST depression ≥1mm (0.1mV) is present in lead 
V4. Discordant ST deviation ≥1mm (0.1mV) in a lead with max (R|S) voltage ≤6mm (0.6mV) 
is present in lead V5. In this figure the Modified Sgarbossa criteria could be considered 
positive in lead V5. However, the ST depression in lead V5 is just below 2mm (0.2mV) and 
falls between 1.5mm (0.15mV) and 2mm (0.2mV); considering this ST deviation 1.5mm 
(0.15mV) or 2mm (0.2mV) make a complete difference with respect to the Modified Sgarbossa 
criteria that become either negative or positive. This example shows how the Modified 
Sgarbossa criteria, which are based on an exact measurement of both QRS amplitude and ST 
deviation, may be difficult to evaluate, especially in the setting of emergency care. By contrast, 
the BARCELONA algorithm, based on simpler cut-offs, may be easier to evaluate and in this 
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